Skip to main content
Back to Kleiner Perkins

Kleiner Perkins's Therapeutics Portfolio

Browse 3 Therapeutics companies funded by Kleiner Perkins. See funding amounts, founder contacts, and investment details.

Therapeutics Companies
3
Total Funding in Therapeutics
$279.5M

Therapeutics Portfolio Companies (3)

Export
Clinical TrialsHealth CareMedical DeviceTherapeutics

Developed the first FDA-cleared digital therapeutic that significantly reduces/eliminates symptoms of panic attacks & PTSD in only 28 days

Kirkland, United States
April 2024
$22.6M
Series E

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareTherapeutics

Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.

San Diego, United States
January 2023
$6.9M
Venture - Series Unknown

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Rapt is focused on the discovery and development of novel small-molecule agents to activate the immune system to eradicate cancer.

South San Francisco, United States
October 2025
$250.0M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

Explore Kleiner Perkins's Full Portfolio

View all companies funded by Kleiner Perkins across every industry and funding stage.

View Full Kleiner Perkins Portfolio